{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T12:43:22Z","timestamp":1778330602459,"version":"3.51.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/ecco-jcc\/jjy142","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T07:09:44Z","timestamp":1538377784000},"page":"12-18","source":"Crossref","is-referenced-by-count":48,"title":["Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab"],"prefix":"10.1093","volume":"13","author":[{"given":"Annick","family":"Moens","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium"},{"name":"Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"van Hoeve","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium"},{"name":"Department of Paediatric Gastroenterology, University Hospitals Leuven, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Humblet","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ziekenhuis Oost-Limburg \u2013 Campus Sint-Jan, Genk, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Rahier","sequence":"additional","affiliation":[{"name":"Deparment of Gastroenterology, CHU UCL Namur, Universit\u00e9 catholique de Louvain, Yvoir, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-7365","authenticated-orcid":false,"given":"Peter","family":"Bossuyt","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Imeldaziekenhuis, Bonheiden, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dewit","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Mariaziekenhuis Noord-Limburg, Overpelt, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Franchimont","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, H\u00f4pital Erasme, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Macken","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Universiteit ziekenhuis Antwerpen, UZA, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Nijs","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sint-Trudo Ziekenhuis, Sint-Truiden, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Posen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AZ Vesalius, Tongeren, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrijs","family":"Strubbe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AZ Sint-Lucas, Gent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneleen","family":"Van Hootegem","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AZ Klina, Brasschaat, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Van Moerkercke","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AZ Groeninge, Kortrijk, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium"},{"name":"Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ferrante","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium"},{"name":"Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Belgian IBD Research and Development group (BIRD)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"key\n\t\t\t\t2018122111380946200_CIT0001","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14740338.2017.1338273","article-title":"A safety assessment of biological therapies targeting the IL-23\/IL-17 axis in inflammatory bowel diseases","volume":"16","author":"Verstockt","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0003","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.crohns.2012.04.009","article-title":"Management of inflammatory bowel disease in pregnancy","volume":"6","author":"Vermeire","year":"2012","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0004","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/apt.14027","article-title":"Editorial: Vedolizumab in pregnancy \u2013 is gut selectivity as good for baby as it is for mum","volume":"45","author":"Shim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2011.05.009","article-title":"Safety of infliximab use during pregnancy","volume":"32","author":"Djokanovic","year":"2011","journal-title":"Reprod Toxicol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0006","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1517\/14740338.2014.973399","article-title":"Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy","volume":"13","author":"Khan","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0007","first-page":"400","article-title":"Long-term efficacy of vedolizumab for ulcerative colitis","volume":"11","author":"Loftus","year":"2017","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0008","first-page":"412","article-title":"Long-term efficacy of vedolizumab for Crohn\u2019s disease","volume":"11","author":"Vermeire","year":"2017","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.14075","article-title":"Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease","volume":"46","author":"Bye","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0010","first-page":"1025","article-title":"Letter: Vedolizumab in pregnancy","volume":"11","author":"Sheridan","year":"2017","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0011","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apt.13960","article-title":"Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease","volume":"45","author":"Mahadevan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0012","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1136\/gutjnl-2016-313444","article-title":"Vedolizumab safety in pregnancy and newborn outcomes","volume":"66","author":"Julsgaard","year":"2017","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0013","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1002\/eji.200425223","article-title":"Functional involvement of P-selectin and MAdCAM-1 in the recruitment of \u03b14\u03b27-integrin-expressing monocyte-like cells to the pregnant mouse uterus","volume":"34","author":"Fernekorn","year":"2004","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0014","unstructured":"Zelinkova Z , BerakovaK, PodmanickyD, KadleckovaB. Placental madcam1 expression and potential consequences for the treatmnt with vedolizumab during pregnancy. Digestive Disease Week, AGA abstract."},{"key":"key\n\t\t\t\t2018122111380946200_CIT0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/apt.12833","article-title":"Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease","volume":"40","author":"Seirafi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0016","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1097\/MIB.0000000000001234","article-title":"Anti-TNF-\u03b1 use during the third trimester of pregnancy in women with moderate-severe inflammatory bowel disease and the risk of preterm birth and low birth weight","volume":"23","author":"Kammerlander","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0017","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","article-title":"Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California","volume":"133","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0018","doi-asserted-by":"crossref","first-page":"e0129567","DOI":"10.1371\/journal.pone.0129567","article-title":"Inflammatory bowel disease and risk of adverse pregnancy outcomes","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0019","volume-title":"Vaccinatieschema K&G","author":"Kind & Gezin","year":"2018"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-\u03b1 inhibitors during IBD pregnancy: a systematic review","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/AOG.0000000000000978","article-title":"Care of the pregnant patient with inflammatory bowel disease","volume":"126","author":"Mahadevan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0022","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s10620-015-3677-x","article-title":"Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis","volume":"60","author":"O\u2019Toole","year":"2015","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0023","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1572-0241.2002.05543.x","article-title":"Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study","volume":"97","author":"Dominitz","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0024","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1572-0241.2007.01355.x","article-title":"Disease activity in pregnant women with Crohn\u2019s disease and birth outcomes: a regional Danish cohort study","volume":"102","author":"N\u00f8rg\u00e5rd","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0025","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohn\u2019s disease and rheumatoid arthritis","volume":"99","author":"Katz","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0026","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/ibd.21583","article-title":"Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy","volume":"17","author":"Schnitzler","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0027","unstructured":"Mahadevan U , MartinCE, SandlerRS, et al PIANO: A 1000 patient prospective registry of pregnancy outcome in women with IBD exposed to immunomodulators and biologic therapy. AGA abstracts."},{"key":"key\n\t\t\t\t2018122111380946200_CIT0028","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ajg.2017.501","article-title":"Long-term safety of in utero exposure to anti-TNF\u03b1 drugs for the treatment of inflammatory bowel disease: results from the Multicenter European TEDDY Study","volume":"113","author":"Chaparro","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41424-018-0018-3","article-title":"Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants","volume":"9","author":"Kattah","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0030","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s10620-015-3992-2","article-title":"The effect of maternal peripartum anti-TNF\u03b1 use on infant immune response","volume":"61","author":"Sheibani","year":"2016","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0032","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"immunological changes in blood of newborns exposed to anti-TNF-\u03b1 during pregnancy","volume":"8","author":"Esteve-Sol\u00e9","year":"2017","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0033","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ecco-jcc\/jjx120","article-title":"Vedolizumab levels in breast milk of nursing mothers with inflammatory bowel disease","volume":"12","author":"Lahat","year":"2018","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018122111380946200_CIT0034","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2017.08.067","article-title":"Vedolizumab concentrations in the breast milk of nursing mothers with inflammatory bowel disease","volume":"154","author":"Julsgaard","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/13\/1\/12\/27235847\/jjy142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T01:07:21Z","timestamp":1571965641000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/13\/1\/12\/5114379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,3]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy142","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,10,3]]}}}